Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-07-03
DOI
10.1093/eurheartj/ehaa574
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3
- (2018) Yu Chen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
- (2017) Ajay Gupta et al. LANCET
- Myotoxicity of statins: Mechanism of action
- (2017) Patrick du Souich et al. PHARMACOLOGY & THERAPEUTICS
- Statins, Muscle Disease and Mitochondria
- (2017) Radha Ramachandran et al. Journal of Clinical Medicine
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
- (2015) Bruce K. Birmingham et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis
- (2014) Ana Filipa Macedo et al. BMC Medicine
- The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
- (2014) L B Ramsey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review
- (2014) William J. Canestaro et al. GENETICS IN MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship?
- (2011) Anne Holbrook et al. CANADIAN JOURNAL OF CARDIOLOGY
- Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy
- (2010) Yiannis S. Chatzizisis et al. DRUG SAFETY
- Review of Side-Effect Profile of Combination Ezetimibe and Statin Therapy in Randomized Clinical Trials
- (2008) Amir Kashani et al. AMERICAN JOURNAL OF CARDIOLOGY
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now